Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Bear follows man, swipes at him on North Vancouver trail

August 24, 2026

Crypto News Today: AlphaPepe Passes $2.5M Presale Milestone as XRP Price Prediction Eyes $3.50

August 24, 2026

Economic study demonstrates scale, grade, long life, growth potential and robust financial returns

August 24, 2026

Southern Alberta charity closes permanently following AHS shutdown

August 24, 2026

Montreal Victoire’s missing Walter Cup trophy found and reunited with team

August 24, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe
Press Release

Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe

By News RoomApril 14, 20262 Mins Read
Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe
Share
Facebook Twitter LinkedIn Pinterest Email

COPENHAGEN, Denmark, April 14, 2026 (GLOBE NEWSWIRE) — Arla Foods Ingredients has developed high-protein, nutrient-dense application concepts for users of GLP-1 anti-obesity medications, which it will showcase at Vitafoods Europe (5th-7th May 2026 in Barcelona).

Originally developed to treat diabetes, GLP-1 receptor agonists have re-shaped the weight management market. In 2025, 11% of consumers globally [1] and 18% in the US [2] who were actively trying to lose weight reported using them, with uptake expected to rise as availability expands, tablet formats emerge and prices fall [3].

However, GLP-1 use is associated with side effects: lean muscle loss may reach 40% of total mass lost, versus around 25% with traditional interventions [4, 5, 6], while up to 76% of GLP-1 consumers report gastric discomfort and reduced appetite [7].

To help manufacturers address these needs, Arla Foods Ingredients has developed high-protein concepts with Nutrilac® and Lacprodan® BLG-100, delivering all essential amino acids for muscle health in nutrient-dense formats, and incorporating probiotics / cultures from Novonesis to support digestive well-being. 

The range includes great-tasting formats for reduced appetites:

  • A fermented, high-protein shot featuring Nutrilac® ProteinBoost, offering 10g of protein per 70ml serving; low fat, lactose-reduced and no added sugar.
  • A fermented, high-protein drinking yoghurt featuring Nutrilac® ProteinBoost and Nutrilac® MFGM, providing 20g protein per 200ml serving; lactose-reduced.
  • A fermented, high-protein spoonable yoghurt featuring Nutrilac® ProteinBoost, Nutrilac® YO-7700, and Capolac® milk minerals, providing 20g protein per 120g serving; high in calcium, low fat and lactose-reduced.
  • A high-protein water-based shot for ambient storage, featuring Lacprodan® BLG-100 and providing 21g of protein per 100ml serving; fat-free, sugar-free and low in lactose.

Anne Widart, Chief Commercial Officer of Arla Foods Ingredients, said: “Nutrition for GLP-1 users is a growing category, creating opportunities for dairy manufacturers. There is increasing demand for nutrient-dense, high-protein products in formats suited to smaller appetites. Our concepts are designed to help manufacturers respond to these evolving needs.”

Arla Foods Ingredients will showcase the GLP-1 companion nutrition solutions at Vitafoods Europe (Stand #3G156) alongside two additional concepts:

  • An aerated protein bar solution made with Nutrilac® PB-8420, offering high-quality milk protein and a light, soft texture enabled by stable air incorporation during processing and shelf life.
  • Ready-to-stir medical nutrition powder solutions made with Lacprodan® BLG-100 Acidic, combining a refreshing taste, no bitterness and low astringency, low viscosity at high protein levels, and good solubility in water, foods and drinks.

Photo https://www.globenewswire.com/NewsRoom/AttachmentNg/debb0da5-3fc7-43ee-93f7-b975d7eab6b0

            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Crypto News Today: AlphaPepe Passes $2.5M Presale Milestone as XRP Price Prediction Eyes $3.50

Economic study demonstrates scale, grade, long life, growth potential and robust financial returns

Abbott International Reaches $1.2 Billion in Assets Under Management

Nursery Bedding and Furniture Global Market Report 2026-2035 | Delta Children's Products Corp., Goodbaby International, IKEA, Dorel Juvenile, and Storkcraft Dominate

Egg Packaging Global Market Report 2026-2035 | CKF, Hartmann Group, Huhtamaki, Pactiv Evergreen, and Tekni-Plex Dominate the Industry

European Football's Corner-Kick Revolution: Goals Surge as Set Pieces Shape Title Races

TTEC RealSkill™ Wins Gold for Best Use of AI for Learning at 2026 Brandon Hall Group™ HCM Excellence Awards

XEAL ENERGY PARTNERS WITH OBAMA PRESIDENTIAL CENTER TO BRING RELIABLE EV CHARGING TO CHICAGO'S SOUTH SIDE

Paybis Widens Its Global Crypto Payment Methods to 20+ as Local Payment Rails Multiply Worldwide

Editors Picks

Crypto News Today: AlphaPepe Passes $2.5M Presale Milestone as XRP Price Prediction Eyes $3.50

August 24, 2026

Economic study demonstrates scale, grade, long life, growth potential and robust financial returns

August 24, 2026

Southern Alberta charity closes permanently following AHS shutdown

August 24, 2026

Montreal Victoire’s missing Walter Cup trophy found and reunited with team

August 24, 2026

Latest News

Lenovo confirms Legion Go issues after gamers report bricked devices

August 24, 2026

Ford government celebrates construction work on northern Ontario mining roads

August 24, 2026

Abbott International Reaches $1.2 Billion in Assets Under Management

August 24, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version